AI ScreeningAI ChatPricing
  1. US-listed companies
  2. U.S. Stem Cell, Inc.
  3. Financials
  4. Operating margin (%)

U.S. Stem Cell, Inc.【USRM】

Market cap
$64.15K
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 2022-2,096.9+97.09%
Dec 31, 2021-1,063.9+22.82%
Dec 31, 2020-866.2+5186.97%
Dec 31, 2018-16.4+12.41%
Dec 31, 2017-14.6-61.24%
Dec 31, 2016-37.6-68.38%
Dec 31, 2015-118.9-30.73%
Dec 31, 2014-171.7-17.20%
Dec 31, 2013-207.3+3.85%
Dec 31, 2012-199.7-9.49%
Dec 31, 2011-220.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)